Paper41174009
Steric stabilization-independent stealth cloak enables nanoreactors-mediated starvation therapy against refractory cancer.
Li J and 13 others. Nat Biomed Eng, 2026. Cited by 4 papers, by iCite.
Cite this record
ConductScience Library. Steric stabilization-independent stealth cloak enables nanoreactors-mediated starvation therapy against refractory cancer. Papers, record 41174009. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41174009
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Steric stabilization-independent stealth cloak enables nanoreactors-mediated starvation therapy against refractory cancer.
- PubMed
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Nanoparticles | Major topic |
| Neoplasms | Major topic |
| Nanostructures | Major topic |
| Animals | |
| Humans | |
| Asparaginase | |
| Mice | |
| Asparagine | |
| Cell Line, Tumor |
Source PubMed
Grants4
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| JPMJPF2202 | MEXT | Japan Science and Technology Agency (JST) | PubMed | ||
| 20K20209 | MEXT | Japan Society for the Promotion of Science (JSPS) | PubMed | ||
| 23H03740 | MEXT | Japan Society for the Promotion of Science (JSPS) | PubMed | ||
| P17356 | MEXT | Japan Society for the Promotion of Science (JSPS) | PubMed |
Source PubMed
Comments and corrections2
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers | Source |
|---|---|---|---|---|
| Erratum in | 41299031 | Author Correction: Steric stabilization-independent stealth cloak enables nanoreactors-mediated starvation therapy against refractory cancer. | https://conductscience.org/library/papers/41299031 | PubMed |
| Erratum in | 41634418 | Author Correction: Steric stabilization-independent stealth cloak enables nanoreactors-mediated starvation therapy against refractory cancer. | https://conductscience.org/library/papers/41634418 | PubMed |
References78
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 19525947 | Understanding biophysicochemical interactions at the nano-bio interface. | Nat Mater | 2009 | https://conductscience.org/library/papers/19525947 | PubMed |
| 2 | 23212421 | Biomolecular coronas provide the biological identity of nanosized materials. | Nat Nanotechnol | 2012 | https://conductscience.org/library/papers/23212421 | PubMed |
| 3 | 2384160 | Amphipathic polyethyleneglycols effectively prolong the circulation time of liposomes. | FEBS Lett | 1990 | https://conductscience.org/library/papers/2384160 | PubMed |
| 4 | 8128245 | Biodegradable long-circulating polymeric nanospheres. | Science | 1994 | https://conductscience.org/library/papers/8128245 | PubMed |
| 5 | 12628324 | PEGylated nanoparticles for biological and pharmaceutical applications. | Adv Drug Deliv Rev | 2003 | https://conductscience.org/library/papers/12628324 | PubMed |
| 6 | 22169873 | Poly(zwitterionic)protein conjugates offer increased stability without sacrificing binding affinity or bioactivity. | Nat Chem | 2011 | https://conductscience.org/library/papers/22169873 | PubMed |
| 7 | 30936455 | Micelles with ultralow critical micelle concentration as carriers for drug delivery. | Nat Biomed Eng | 2018 | https://conductscience.org/library/papers/30936455 | PubMed |
| 8 | 11496942 | Cisplatin-loaded polymer-metal complex micelle with time-modulated decaying property as a novel drug delivery system. | Pharm Res | 2001 | https://conductscience.org/library/papers/11496942 | PubMed |
| 9 | 14695216 | Novel cisplatin-incorporated polymeric micelles can eradicate solid tumors in mice. | Cancer Res | 2003 | https://conductscience.org/library/papers/14695216 | PubMed |
| 10 | 15588907 | Preparation and biological properties of dichloro(1,2-diaminocyclohexane)platinum(II) (DACHPt)-loaded polymeric micelles. | J Control Release | 2005 | https://conductscience.org/library/papers/15588907 | PubMed |
| 11 | 11251249 | Block copolymer micelles for drug delivery: design, characterization and biological significance. | Adv Drug Deliv Rev | 2001 | https://conductscience.org/library/papers/11251249 | PubMed |
| 12 | 19555070 | Soluble polymer carriers for the treatment of cancer: the importance of molecular architecture. | Acc Chem Res | 2009 | https://conductscience.org/library/papers/19555070 | PubMed |
| 13 | 22191645 | Nanoparticle size and surface chemistry determine serum protein adsorption and macrophage uptake. | J Am Chem Soc | 2012 | https://conductscience.org/library/papers/22191645 | PubMed |
| 14 | 22920324 | PEGylated PRINT nanoparticles: the impact of PEG density on protein binding, macrophage association, biodistribution, and pharmacokinetics. | Nano Lett | 2012 | https://conductscience.org/library/papers/22920324 | PubMed |
| 15 | 24521246 | Evading immune cell uptake and clearance requires PEG grafting at densities substantially exceeding the minimum for brush conformation. | Mol Pharm | 2014 | https://conductscience.org/library/papers/24521246 | PubMed |
| 16 | 28974673 | Mechanistic understanding of in vivo protein corona formation on polymeric nanoparticles and impact on pharmacokinetics. | Nat Commun | 2017 | https://conductscience.org/library/papers/28974673 | PubMed |
| 17 | 29957926 | Block Copolymer Micelles in Nanomedicine Applications. | Chem Rev | 2018 | https://conductscience.org/library/papers/29957926 | PubMed |
| 18 | 37211278 | Stealth and pseudo-stealth nanocarriers. | Adv Drug Deliv Rev | 2023 | https://conductscience.org/library/papers/37211278 | PubMed |
| 19 | 353875 | Thermodynamic analysis of ion effects on the binding and conformational equilibria of proteins and nucleic acids: the roles of ion association or release, screening, and ion effects on water activity. | Q Rev Biophys | 1978 | https://conductscience.org/library/papers/353875 | PubMed |
| 20 | 3333131 | Adsorption of proteins from solution at the solid-liquid interface. | Adv Colloid Interface Sci | 1986 | https://conductscience.org/library/papers/3333131 | PubMed |
Cited by3
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 4 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42916086 | Boosting Ligand-Mediated Hepatic mRNA Delivery and Gene Editing Through Coordinated Pairing of Polyethylene Glycol-Modified Lipids. | ACS Nano | 2026 | https://conductscience.org/library/papers/42916086 | PubMed |
| 42657191 | Graphene and Graphene Oxide-Based Nanocarriers for Targeted Delivery of Mitoxantrone in Cancer Therapy. | Int J Nanomedicine | 2026 | https://conductscience.org/library/papers/42657191 | PubMed |
| 42251617 | Stimuli-responsive nanogels as intelligent nanocarriers for tumor microenvironment-triggered anticancer drug delivery. | Discov Nano | 2026 | https://conductscience.org/library/papers/42251617 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41174009
GET https://conductscience.org/api/papers/v1/41174009/references?page=2